$3.02B in CY2024 Part D spend391K claims · 61K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Valbenazine used for?
INGREZZA and INGREZZA SPRINKLE are indicated for the treatment of adults with: - tardive dyskinesia [see Clinical Studies ( 14.1 )] . - chorea associated with Huntington’s disease [see Clinical Stu....
Is there a generic for Valbenazine?
Yes. 2 ANDAs filed at FDA, 1 generic manufacturers currently shipping.
How much does my plan pay for Valbenazine?
Across 329 Part D plans, Valbenazine averages $275.24/unit (NADAC). Lowest available: $259.07/unit. Highest in distribution: $283.32/unit.
Is Valbenazine on the FDA shortage list?
No. Valbenazine is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (8 approvals on file) · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.